ApoB test may be more accurate measure of heart disease risk, claims JAMA study Dr. Kamal Kant Kohli17 Aug 2024 9:30 AM ISTThe traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT...
Low-Dose DOAC Offers Superior Balance of Efficacy and Safety Over DAPT After LAAO: ADALA Trial Medha Baranwal13 Aug 2024 12:00 PM ISTSpain: In a new study published in JAMA Cardiology, the ADALA randomized clinical trial has unveiled new insights into post-procedural care following...
Cardiac CECT can accurately localize fatty tissue in heart, paving way for better heart treatment strategies: JAMA Medha Baranwal9 Aug 2024 8:30 AM ISTUSA: A recent cohort study published in JAMA Cardiology found that contrast-enhanced computed tomography (CECT) can help localize fatty tissue in the...
Leadless CRT system Using Ultrasound Energy Offers New Option for Heart Failure Management: SOLVE-CRT Study Medha Baranwal6 Aug 2024 10:00 AM ISTUSA: A leadless left ventricular (LV) using ultrasound energy is promising as a viable alternative for patients with failed coronary sinus (CS) lead...
Dapagliflozin Enhances Right Ventricular Function in Heart Failure Patients, shows study Medha Baranwal27 July 2024 9:30 AM ISTUSA: Dapagliflozin enhances right ventricular pulsatile afterload and myocardial performance during exercise, which correlates with a reduction in...
High Plasma Lipoprotein(a) tied to faster hemodynamic progression in aortic stenosis patients: JAMA Medha Baranwal20 July 2024 9:45 AM ISTCanada: A recent meta-analysis published in JAMA Cardiology has revealed an association between higher plasma lipoprotein(a) concentrations and faster...
JAMA: No sex-specific differences observed in aspirin for the secondary prevention of ASCVD Jacinthlyn Sylvia17 July 2024 9:00 AM ISTA new analysis from the ADAPTABLE clinical trial unveiled no significant difference observed in safety and effectiveness between two aspirin dosages...
Lower Dose Anticoagulants Safe and Effective for Elderly Atrial Fibrillation Patients: JAMA Medha Baranwal16 July 2024 10:00 AM ISTUSA: Patients aged 80 years and older with atrial fibrillation (AF) may consider lower-dose anticoagulants, such as 30 mg once daily of edoxaban,...
Plasma Proteome in Early Pregnancy Falls Short in Predicting Hypertensive Disorders: JAMA Medha Baranwal16 July 2024 7:15 AM ISTUSA: A recent study published in JAMA Cardiology has found that the plasma proteome in the first trimester of pregnancy did not prove clinically...
Study Highlights Long-Term Potential of Lerodalcibep in LDL-C Treatment for High-Risk CVD Patients Medha Baranwal13 July 2024 9:15 AM ISTUSA: Findings from a recent study support the long-term use of lerodalcibep for low-density lipoprotein cholesterol (LDL-C) treatment for patients...
POST-PCI Trial: Surveillance stress testing at 12 months offers no added benefit in high-risk PCI patients, regardless of ACS status Medha Baranwal8 July 2024 9:00 AM ISTSouth Korea: In the realm of post-percutaneous coronary intervention (PCI) care, the debate over the necessity of routine stress testing continues to...
Research Shows How Your Genes Could Predict Your Atrial Fibrillation Risk Anshika Mishra8 July 2024 8:15 AM ISTYour genes influence your risk of developing the heart condition atrial fibrillation, a large-scale genetic survey has shown. This may prevent cases...
